Health Care/Hospital
MGI and King Abdullah International Medical Research Center Announce Partnership for Genomic Research
The new agreement will enable cutting-edge research aimed at preventing disease and improving health while supporting specialized training of healthcare professionals and scientists. RIYADH, Saudi Arabia, May 31, 2022 /PRNewswire/ -- Global life science innovator MGI Tech Co. Ltd. (MGI) and King...
2022-05-31 20:33
1975
ETNA™ DEVICE FROM THE LEADING DIGITAL HEALTH & AI COMPANY INNODEM NEUROSCIENCES RECEIVES FDA "BREAKTHROUGH" DESIGNATION FOR MULTIPLE SCLEROSIS
MONTREAL, May 31, 2022 /PRNewswire/ -- Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital health, pharmaceutical and artificial intelligence, is proud to announce that its novel mobile eye tracking technology for people living with...
2022-05-31 18:00
1415
DSM and Firmenich to merge, becoming the leading creation and innovation partner in nutrition, beauty and well-being
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE INTHE UNITED STATES – SEE FURTHER INFORMAT...
2022-05-31 13:00
2353
Winner Medical Announces to Acquire 55% Stake in Zhejiang Longterm Medical for US $108.2 Million
SHENZHEN, China, May 31, 2022 /PRNewswire/ -- On April 10 Winner Medical announced that it has signed a definitive agreement to acquire 55% stake in Zhejiang Longterm Medical Technology Co., Ltd. for US$108.2 million. Winner Medical believes that the acquisition aligns with the company's strateg...
2022-05-31 11:35
2407
Medical training in Vietnam impressively attracts international students.
HO CHI MINH CITY, Vietnam, May 30, 2022 /PRNewswire/ -- In the last few days of May, many colleagues fromIndia, Honduras, Nigeria, etc., came to Vietnam to be admitted to the Medical Major of Hong BangInternational University (HIU). This is a significant milestone for the Vietnamese board of educ...
2022-05-30 20:08
2899
Golden Meditech Stem Cells Responds to Blue Ocean's misleading 13D/A filing
HONG KONG, May 30, 2022 /PRNewswire/ -- Golden Meditech Stem Cells (BVI) Company Limited (the "Company"), would like to respond to the misleading Schedule 13D/A filed by Blue Ocean Structure Investment Company Ltd. ("Blue Ocean") onMay 27, 2022. Blue Ocean failed to mention in its Schedule 13D/A...
2022-05-30 19:31
2186
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment
GAITHERSBURG, Md. and SUZHOU, China, May 30, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today the launch of a Phase I clinical trial of the Company's si...
2022-05-30 16:40
2113
Experts attending P&G Health's Global Webinar Series highlight underdiagnosis concerns as Peripheral Neuropathy becomes more prevalent
- Often underestimated and diagnosed late, increasing awareness and early-stage screening of Peripheral Neuropathy by primary care physicians can help prevent long-term complications and quality of life restrictions. - The Global Webinar Series for healthcare professionals has 'Virtual Pavilions...
2022-05-30 16:12
2263
Northern Health using The Clinician's digital health platform to expand their Victorian Virtual Emergency Department Statewide
MELBOURNE, Australia, May 30, 2022 /PRNewswire/ --
2022-05-30 13:18
2401
UAE powerhouse VPS Healthcare launches Burjeel Holdings to scale the next generation of its growth
On the sidelines of the World Economic Forum Annual Meeting, the UAE-based private healthcare organization launched the holding company to consolidate its offerings. DAVOS, Switzerland, May 30, 2022 /PRNewswire/ -- The UAE-based VPS Healthcare has announced the launch of Burjeel Holdings on the...
2022-05-30 11:27
2768
RhoVac's phase IIb study in prostate cancer , BRaVac, failed to meet its primary endpoint
STOCKHOLM, May 30, 2022 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, regrets to announce today onMay 29th, 2022, that its phase IIb study in prostate cancer, BRaVac, in spite of the previous positive results related to the compound, failed to demonstrate RV001 (on...
2022-05-30 11:04
1623
United BioPharma Receives TFDA Approval for Phase 2 IND for UB-221 to Treat Chronic Spontaneous Urticaria
TAIPEI, May 30, 2022 /PRNewswire/ -- Taiwan-based United BioPharma (UBP) has
announced the approval of a Phase 2 clinical trial with novel anti-IgE
monoclonal antibody UB-221 by the Taiwan Food and Drug Administration (TFDA).
2022-05-30 10:59
1661
Illuccix® Reimbursement Milestone and Launch Updates: Pass-Through Status Granted in the U.S.
MELBOURNE, Australia and INDIANAPOLIS, May 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on the U.S. and Australian launch and reimbursement status for its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium (68...
2022-05-30 08:02
2580
MedAlliance's SELUTION SLR drug-eluting balloon (DEB) receives FDA investigational device exemption (IDE) approval, making it the first limus DEB to be available to US patients
GENEVA, May 30, 2022 /PRNewswire/ -- The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted "breakthrough device de...
2022-05-30 08:00
2084
Embracing Win-win Cooperation - ASEAN Consul Generals, officials and representatives of chambers of commerce in Guangzhou visited Biosyngen
GUANGZHOU, China, May 28, 2022 /PRNewswire/ -- On the morning of May 27, 2022, Mr.Loh Tuck Keat, Consul General of Singapore in Guangzhou, and representatives of Consulates General and Chambers of Commerce of eight countries, namely Malaysia, Philippines, Laos, Vietnam, Indonesia, Thailand and Cam...
2022-05-28 09:00
6646
Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutralizing efficacy
TAIPEI, May 27, 2022 /PRNewswire/ -- Taiwanese biotech outfit AcadeMab has broken new ground in the development of COVID immunotherapies through the development of a potentially life-saving monoclonal antibodies for COVID-19 patients using single B cell technology, shows the best neutralization a...
2022-05-27 11:40
2727
Adagene Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody® ADG126, with Repeat Dosing Across Dose Levels
- First clinical data demonstrating potential of SAFEbody technology platform to create best-in-class therapeutics - - Additional data from ongoing ADG126 clinical program to be presented in second half of 2022, including safety in combination with anti-PD-1 therapies - SAN DIEGO and SUZHOU, Chi...
2022-05-27 09:30
4882
Menarini inaugurates new regional headquarters in Dubai, UAE
The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across theMiddle East and Africa (MEA) region with innovative products and breakthrough research DUBAI, UAE, May 26, 2022 /PRNewswire/ -- Menarini, the leading Italian pharmaceutical gro...
2022-05-26 23:16
2915
ROVENSA becomes global leader in BioSolutions through the integration of COSMOCEL
* COSMOCEL is a leader in specialty biostimulants with a high value-added portfolio and a consolidated commercial footprint inNorth America, Latin America ,Europe, Middle East, and South Africa. * This strategic step transforms ROVENSA into global leader in BioSolutions for sustainable agricul...
2022-05-26 23:08
3011
US FDA Clears IND for Cynata's Phase 2 Clinical Trial of CYP-001 in GvHD
Key Highlights: * US FDA has cleared Cynata's IND application for a Phase 2 clinical trial of CYP-001 in patients with aGvHD – a major milestone and value catalyst for the Company * Phase 2 clinical study in aGvHD expected to commence subsequent to customary and satisfactory completion of ne...
2022-05-26 20:44
2122
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5482
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4443
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4034
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3294
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
3039